Stay updated with breaking news from Alexandero schuth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have earned a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the company, MarketBeat reports. Thirteen research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock […] ....
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 327,468 shares traded hands during mid-day trading, a decline of 53% from the previous session’s volume of 690,950 shares.The stock last traded at $21.76 and had previously closed at $22.29. Analysts Set New Price Targets DNLI has been the […] ....
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $23.84, but opened at $24.57. Denali Therapeutics shares last traded at $24.03, with a volume of 48,555 shares changing hands. Analyst Upgrades and Downgrades Several brokerages recently issued reports on […] ....
HC Wainwright restated their buy rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research report report published on Thursday morning, Benzinga reports. They currently have a $105.00 price target on the stock. DNLI has been the subject of several other research reports. Wedbush decreased their price objective on Denali Therapeutics from […] ....
Denali Therapeutics (NASDAQ:DNLI) Earns Overweight Rating from Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.